Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Cranmer LD"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-14 z 14
    Tytuł:
    Intracranial Solitary Fibrous Tumor/Hemangiopericytoma Treated with Microsurgical Resection: Retrospective Cohort Analysis of a Single-Center Experience
    Autorzy:
    Swaminathan S
    Ruzevick J
    Venur V
    Halasz LM
    Rockhill J
    Gonzalez-Cuyar L
    Cranmer LD
    Ferreira Jnr M
    Pokaż więcej
    Temat:
    solitary fibrous tumor
    hemangiopericytoma
    radiotherapy
    embolization
    adjuvant
    Therapeutics. Pharmacology
    RM1-950
    Źródło:
    Therapeutics and Clinical Risk Management, Vol Volume 18, Pp 901-912 (2022)
    Opis pliku:
    electronic resource
    Relacje:
    https://www.dovepress.com/intracranial-solitary-fibrous-tumorhemangiopericytoma-treated-with-mic-peer-reviewed-fulltext-article-TCRM; https://doaj.org/toc/1178-203X
    Dostęp URL:
    https://doaj.org/article/0aa380cb1fef4c10878ad0c878a8c0d6  Link otwiera się w nowym oknie
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Spotlight on aldoxorubicin (INNO-206) and its potential in the treatment of soft tissue sarcomas: evidence to date
    Autorzy:
    Cranmer LD
    Pokaż więcej
    Temat:
    Aldoxorubicin
    INNO-206
    sarcoma
    doxorubicin
    anthracycline
    Neoplasms. Tumors. Oncology. Including cancer and carcinogens
    RC254-282
    Źródło:
    OncoTargets and Therapy, Vol Volume 12, Pp 2047-2062 (2019)
    Opis pliku:
    electronic resource
    Relacje:
    https://www.dovepress.com/spotlight-on-aldoxorubicin-inno-206-and-its-potential-in-the-treatment-peer-reviewed-article-OTT; https://doaj.org/toc/1178-6930
    Dostęp URL:
    https://doaj.org/article/6a1811f9adc841b3919e50420169cc31  Link otwiera się w nowym oknie
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Propranolol for the treatment of vascular sarcomas
    Autorzy:
    Wagner MJ
    Cranmer LD
    Loggers ET
    Pollack SM
    Pokaż więcej
    Temat:
    propranolol
    angiosarcoma
    vascular sarcoma
    cancer
    Therapeutics. Pharmacology
    RM1-950
    Źródło:
    Journal of Experimental Pharmacology, Vol Volume 10, Pp 51-58 (2018)
    Opis pliku:
    electronic resource
    Relacje:
    https://www.dovepress.com/propranolol-for-the-treatment-of-vascular-sarcomas-peer-reviewed-fulltext-article-JEP; https://doaj.org/toc/1179-1454
    Dostęp URL:
    https://doaj.org/article/0f6355e46999417183f782ba62f3896e  Link otwiera się w nowym oknie
    Czasopismo naukowe
    Szczegóły
    Tytuł:
    Pazopanib in the management of advanced soft tissue sarcomas
    Autorzy:
    Cranmer LD
    Loggers ET
    Pollack SM
    Pokaż więcej
    Temat:
    pazopanib
    sarcoma
    angiogenesis
    soft-tissue sarcoma
    Therapeutics. Pharmacology
    RM1-950
    Źródło:
    Therapeutics and Clinical Risk Management, Vol 2016, Iss Issue 1, Pp 941-955 (2016)
    Opis pliku:
    electronic resource
    Relacje:
    https://www.dovepress.com/pazopanib-in-the-management-of-advanced-soft-tissue-sarcomas-peer-reviewed-article-TCRM; https://doaj.org/toc/1178-203X
    Dostęp URL:
    https://doaj.org/article/cc9358f6f781456c95ff7e50a45adbcc  Link otwiera się w nowym oknie
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Incidence, demographics, and survival of malignant hemangioendothelioma in the United States.
    Autorzy:
    Paulson KG; Medical Oncology, Providence-Swedish Cancer Institute, Seattle, Washington, USA.
    Ravi V; Sarcoma Medical Oncology, MD Anderson Cancer Center, Houston, Texas, USA.
    Rubin BP; Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio, USA.
    Park M; Medical Oncology, Providence-Swedish Cancer Institute, Seattle, Washington, USA.
    Loggers ET; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Division of Medical Oncology, University of Washington, Seattle, Washington, USA.
    Cranmer LD; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Division of Medical Oncology, University of Washington, Seattle, Washington, USA.
    Wagner MJ; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Division of Medical Oncology, University of Washington, Seattle, Washington, USA.
    Pokaż więcej
    Źródło:
    Cancer medicine [Cancer Med] 2023 Jul; Vol. 12 (14), pp. 15101-15106. Date of Electronic Publication: 2023 Jun 01.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Hemangioendothelioma, Epithelioid*/epidemiology
    Hemangioendothelioma, Epithelioid*/pathology
    Hemangiosarcoma*/pathology
    Hemangioendothelioma*/epidemiology
    Hemangioendothelioma*/pathology
    Adolescent ; Young Adult ; Humans ; Child ; United States/epidemiology ; Middle Aged ; Incidence ; Retrospective Studies
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Immunologic Gene Signature Analysis Correlates Myeloid Cells and M2 Macrophages with Time to Trabectedin Failure in Sarcoma Patients.
    Autorzy:
    Schroeder BA; National Cancer Institute, National Institutes of Health, Bethesda, MD 20829, USA.; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
    Zhang Y; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
    Smythe KS; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
    Desai P; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20829, USA.
    Thomas A; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20829, USA.
    Viveiros P; Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.
    Alexiev BA; Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.
    Obeidin F; Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.
    Chen EY; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98195, USA.
    Cranmer LD; Department of Medical Oncology, University of Washington, Seattle, WA 98195, USA.
    Wagner MJ; Department of Medical Oncology, University of Washington, Seattle, WA 98195, USA.
    Jones RL; Sarcoma Unit, Royal Marsden Hospital NHS Trust and Institute of Cancer Research, London SW3 6JJ, UK.
    Campbell JS; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98195, USA.
    Pierce RH; Sensei Biotherapeutics, Boston, MA 02120, USA.
    He Q; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
    Pollack SM; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.; Division of Oncology, Northwestern University, Chicago, IL 60611, USA.
    Pokaż więcej
    Źródło:
    Cancers [Cancers (Basel)] 2022 Mar 02; Vol. 14 (5). Date of Electronic Publication: 2022 Mar 02.
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Outcomes of Patients with Sarcoma and COVID-19 Infection: A Single Institution Cohort Analysis.
    Autorzy:
    Wagner MJ; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, Washington, USA.; Clinical Research Division, Fred Hutchinson Cancer Research Center (FHCRC), Seattle, Washington, USA.
    Pollack SM; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, Washington, USA.; Clinical Research Division, Fred Hutchinson Cancer Research Center (FHCRC), Seattle, Washington, USA.
    Cranmer LD; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, Washington, USA.; Clinical Research Division, Fred Hutchinson Cancer Research Center (FHCRC), Seattle, Washington, USA.
    Thompson MJ; Department of Orthopedic Surgery, University of Washington, Seattle, Washington, USA.
    Maxwell S; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, Washington, USA.
    Wright S; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, Washington, USA.
    Khaki AR; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, Washington, USA.; Clinical Research Division, Fred Hutchinson Cancer Research Center (FHCRC), Seattle, Washington, USA.
    Madeleine MM; Department of Epidemiology, University of Washington and Public Health Sciences Division, FHCRC, Seattle, Washington, USA.
    Grivas P; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, Washington, USA.; Clinical Research Division, Fred Hutchinson Cancer Research Center (FHCRC), Seattle, Washington, USA.
    Kuderer NM; Advanced Cancer Research Group, Seattle, Washington, USA.
    Lyman GH; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, Washington, USA.; Clinical Research Division, Fred Hutchinson Cancer Research Center (FHCRC), Seattle, Washington, USA.
    Loggers ET; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, Washington, USA.; Clinical Research Division, Fred Hutchinson Cancer Research Center (FHCRC), Seattle, Washington, USA.
    Pokaż więcej
    Źródło:
    Cancer investigation [Cancer Invest] 2021 Apr; Vol. 39 (4), pp. 315-320. Date of Electronic Publication: 2021 Mar 26.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    COVID-19/*prevention & control
    SARS-CoV-2/*isolation & purification
    Sarcoma/*therapy
    Soft Tissue Neoplasms/*therapy
    Adult ; Aged ; COVID-19/complications ; COVID-19/virology ; COVID-19 Testing/methods ; Chemoradiotherapy/methods ; Female ; Humans ; Male ; Middle Aged ; Outcome Assessment, Health Care/methods ; Outcome Assessment, Health Care/statistics & numerical data ; Retrospective Studies ; Risk Factors ; SARS-CoV-2/physiology ; Sarcoma/complications ; Sarcoma/surgery ; Soft Tissue Neoplasms/complications ; Soft Tissue Neoplasms/surgery ; Survival Analysis ; Young Adult
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Identification and quantitation of clinically relevant microbes in patient samples: Comparison of three k-mer based classifiers for speed, accuracy, and sensitivity.
    Autorzy:
    Watts GS; University of Arizona Cancer Center and Department of Pharmacology, University of Arizona, Tucson, Arizona, United States of America.
    Thornton JE Jr; Department of Biosystems Engineering, University of Arizona, Tucson, Arizona, United States of America.
    Youens-Clark K; Department of Biosystems Engineering, University of Arizona, Tucson, Arizona, United States of America.
    Ponsero AJ; Department of Biosystems Engineering, University of Arizona, Tucson, Arizona, United States of America.
    Slepian MJ; Department of Medicine, University of Arizona, Tucson, Arizona, United States of America.; Department of Biomedical Engineering, University of Arizona, Tucson, Arizona, United States of America.; Arizona Center for Accelerated Biomedical Innovation, University of Arizona, Tucson, Arizona, United States of America.
    Menashi E; Honor Health Hospital, Scottsdale, Arizona, United States of America.
    Hu C; Dignity Health Chandler Regional Medical Center, Chandler, Arizona, United States of America.
    Deng W; Department of Endocrinology, Multidisciplinary Diabetic Foot Medical Center, Affiliated Central Hospital of Chongqing University, Chongqing, China.
    Armstrong DG; Southwestern Academic Limb Salvage Alliance (SALSA), Department of Surgery, Keck School of Medicine of University of Southern California, Los Angeles, California, United States of America.
    Reed S; University of Arizona Department of Family and Community Medicine, Tucson, Arizona, United States of America.
    Cranmer LD; Department of Medicine, University of Washington and Fred Hutchinson Cancer Research Center, and Seattle Cancer Care Alliance, Seattle, Washington, United States of America.
    Hurwitz BL; Department of Biosystems Engineering, University of Arizona, Tucson, Arizona, United States of America.; BIO5 Institute, University of Arizona, Tucson, Arizona, United States of America.
    Pokaż więcej
    Źródło:
    PLoS computational biology [PLoS Comput Biol] 2019 Nov 22; Vol. 15 (11), pp. e1006863. Date of Electronic Publication: 2019 Nov 22 (Print Publication: 2019).
    Typ publikacji:
    Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Bacteria/*genetics
    Bacteria/*isolation & purification
    Metagenomics/*methods
    Algorithms ; DNA Barcoding, Taxonomic/methods ; High-Throughput Nucleotide Sequencing ; Humans ; Metagenome ; Microbiota/genetics ; Sensitivity and Specificity ; Sequence Analysis, DNA/methods
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Performance of a prognostic 31-gene expression profile in an independent cohort of 523 cutaneous melanoma patients.
    Autorzy:
    Zager JS; Department of Cutaneous Oncology, Moffitt Cancer Center, 10920 N. McKinley Drive room 4123, Tampa, FL, 33612, USA.
    Gastman BR; Department of Plastic Surgery, Cleveland Clinic Lerner Research Institute, 9500 Euclid Avenue, Cleveland, OH, 44195, USA.
    Leachman S; Department of Dermatology, Knight Cancer Institute, Oregon Health & Science University, 3303 S.W. Bond Avenue, Portland, OR, 97239, USA.
    Gonzalez RC; Department of Medical Oncology, University of Colorado School of Medicine, 12801 E. 17th Avenue, Aurora, CO, 80045, USA.
    Fleming MD; Department of Surgical Oncology, The University of Tennessee Health Science Center, 910 Madison, Suite 303, Memphis, TN, 38163, USA.
    Ferris LK; Department of Dermatology, University of Pittsburgh Medical Center, 3601 Fifth Avenue, Pittsburgh, PA, 15213, USA.
    Ho J; Department of Pathology, University of Pittsburgh Medical Center, 3708 Fifth Avenue, Suite 500.94, Pittsburgh, PA, 15213, USA.
    Miller AR; START Center for Cancer Care, 4383 Medical Drive, San Antonio, TX, 78229, USA.
    Cook RW; Castle Biosciences, Inc., 820 S. Friendswood Drive, Suite 201, Friendswood, TX, 77546, USA.
    Covington KR; Castle Biosciences, Inc., 820 S. Friendswood Drive, Suite 201, Friendswood, TX, 77546, USA.
    Meldi-Plasseraud K; Castle Biosciences, Inc., 820 S. Friendswood Drive, Suite 201, Friendswood, TX, 77546, USA.
    Middlebrook B; Castle Biosciences, Inc., 820 S. Friendswood Drive, Suite 201, Friendswood, TX, 77546, USA.
    Kaminester LH; Dermatology North Palm Beach, 840 U.S. Highway Number One, North Palm Beach, FL, 33408, USA.
    Greisinger A; Research & Development, Kelsey Research Foundation, 5615 Kirby Drive, Suite 660, Houston, TX, 77005, USA.
    Estrada SI; Affiliated Dermatology, 20401 North 73rd Street, Suite 230, Scottsdale, AZ, 85255, USA.
    Pariser DM; Pariser Dermatology Specialists, Virginia Clinical Research, Inc., 6160 Kempsville Circle, Suite 200A, Norfolk, VA, 23502, USA.; Eastern Virginia Medical School, P.O. Box 1980, Norfolk, VA, 23501-1980, USA.
    Cranmer LD; Department of Sarcoma Medical Oncology, Seattle Cancer Care Alliance, 825 Eastlake Avenue E, Seattle, WA, 98109, USA.
    Messina JL; Department of Anatomic Pathology, Moffitt Cancer Center, 10920 N. McKinley Drive, Tampa, FL, 33612, USA.
    Vetto JT; Division of Surgical Oncology, Knight Cancer Institute, Oregon Health & Science University, 3303 S.W. Bond Avenue, Portland, OR, 97239, USA.
    Wayne JD; Department of Surgical Oncology, Northwestern University Feinberg School of Medicine, 251 East Huron Street, Chicago, IL, 60611, USA.; Department of Dermatology, Northwestern University Feinberg School of Medicine, 676 North St. Clair Street, Suite 1600, Chicago, IL, 60611, USA.; Skin Cancer Institute, Northwestern University, Lurie Comprehensive Cancer Center, 420 East Superior Street, Chicago, IL, 60611, USA.
    Delman KA; Department of Surgery, Emory University Winship Cancer Institute, 1364 Clifton Road NE, Atlanta, GA, 30322, USA.
    Lawson DH; Department of Hematology and Medical Oncology, Emory University Winship Cancer Institute, 550 Peachtree Street NE, Atlanta, GA, 30308, USA.
    Gerami P; Skin Cancer Institute, Northwestern University, Lurie Comprehensive Cancer Center, 420 East Superior Street, Chicago, IL, 60611, USA. .; Departments of Dermatology and Pathology, Northwestern University Feinberg School of Medicine, 676 North St. Clair Street, Arkes 1600, Chicago, IL, 60611, USA. .
    Pokaż więcej
    Źródło:
    BMC cancer [BMC Cancer] 2018 Feb 05; Vol. 18 (1), pp. 130. Date of Electronic Publication: 2018 Feb 05.
    Typ publikacji:
    Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Gene Expression Regulation, Neoplastic*
    Gene Expression Profiling/*methods
    Melanoma/*genetics
    Skin Neoplasms/*genetics
    Adolescent ; Adult ; Aged ; Aged, 80 and over ; Cohort Studies ; Gene Expression Profiling/statistics & numerical data ; Humans ; Kaplan-Meier Estimate ; Lymphatic Metastasis ; Melanoma/pathology ; Middle Aged ; Neoplasm Recurrence, Local ; Neoplasm Staging ; Prognosis ; Proportional Hazards Models ; Sentinel Lymph Node Biopsy ; Skin Neoplasms/pathology ; Young Adult
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Vorinostat synergizes with ridaforolimus and abrogates the ridaforolimus-induced activation of AKT in synovial sarcoma cells.
    Autorzy:
    Morgan SS
    Cranmer LD; The University of Arizona Cancer Center, 1515 N, Campbell Avenue, Tucson, AZ 85724-5024, USA. .
    Pokaż więcej
    Źródło:
    BMC research notes [BMC Res Notes] 2014 Nov 18; Vol. 7, pp. 812. Date of Electronic Publication: 2014 Nov 18.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Antineoplastic Combined Chemotherapy Protocols/*pharmacology
    Proto-Oncogene Proteins c-akt/*metabolism
    Sarcoma, Synovial/*enzymology
    Cell Line, Tumor ; Cell Survival/drug effects ; Dose-Response Relationship, Drug ; Doxorubicin/pharmacology ; Drug Synergism ; Enzyme Activation ; Histone Deacetylase Inhibitors/pharmacology ; Humans ; Hydroxamic Acids/pharmacology ; Inhibitory Concentration 50 ; Melphalan/pharmacology ; Molecular Targeted Therapy ; Phosphorylation ; Protein Kinase Inhibitors/pharmacology ; Sarcoma, Synovial/pathology ; Sirolimus/analogs & derivatives ; Sirolimus/pharmacology ; TOR Serine-Threonine Kinases/antagonists & inhibitors ; TOR Serine-Threonine Kinases/metabolism ; Vorinostat
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Ipilimumab pharmacotherapy in patients with metastatic melanoma.
    Autorzy:
    Jeter JM; Department of Medicine, Arizona Cancer Center, University of Arizona, Tucson, AZ, USA.
    Cranmer LD
    Hersh EM
    Pokaż więcej
    Źródło:
    Clinical Medicine Insights. Oncology [Clin Med Insights Oncol] 2012; Vol. 6, pp. 275-86. Date of Electronic Publication: 2012 Jul 30.
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
      Wyświetlanie 1-14 z 14

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies